The document provides information about hepatitis B virus (HBV) including its causes, transmission, signs and symptoms, prevention, and the differences between acute and chronic infection. Some key points:
- HBV is a serious liver infection caused by the hepatitis B virus that can be either acute (less than 6 months) or chronic (lasting over 6 months, increasing risk of liver damage).
- It spreads through contact with infected blood and body fluids and can be prevented with vaccination.
- Symptoms range from mild to severe including abdominal pain, jaundice, fatigue and nausea. Chronic infection often has no symptoms.
- Having unprotected sex, sharing needles, needle sticks or being born to an infected
Comprehending Hepatitis B: Origins, Signs, Preventive measures, and Managementkkaif2906
Hepatitis B is a viral infection that primarily affects the liver. It is caused by the Hepatitis B virus (HBV), which can be transmitted through contact with infected blood, semen, or other bodily fluids. Hepatitis B can manifest as an acute or chronic condition, with symptoms including fatigue, fever, nausea, abdominal pain, and jaundice. Chronic Hepatitis B can lead to serious liver complications such as cirrhosis and liver cancer. Prevention strategies include vaccination, practicing safe sex, avoiding needle sharing, and screening pregnant women for HBV. While there is no cure for Hepatitis B, antiviral medications can help manage the infection and reduce the risk of complications. Regular monitoring is essential for individuals with chronic Hepatitis B to assess disease progression and determine the need for treatment adjustments.
Comprehending Hepatitis B: Origins, Signs, Preventive measures, and Managementkkaif2906
Hepatitis B is a viral infection that primarily affects the liver. It is caused by the Hepatitis B virus (HBV), which can be transmitted through contact with infected blood, semen, or other bodily fluids. Hepatitis B can manifest as an acute or chronic condition, with symptoms including fatigue, fever, nausea, abdominal pain, and jaundice. Chronic Hepatitis B can lead to serious liver complications such as cirrhosis and liver cancer. Prevention strategies include vaccination, practicing safe sex, avoiding needle sharing, and screening pregnant women for HBV. While there is no cure for Hepatitis B, antiviral medications can help manage the infection and reduce the risk of complications. Regular monitoring is essential for individuals with chronic Hepatitis B to assess disease progression and determine the need for treatment adjustments.
all information about
it include :-
1- DEFINITION
2- SIGNS AND SYMPTOMS
3- MECHANISM
4- RISK FACTOR
5- COMPLICATIONS
6- PRECAUTION
7- PREVENTION
8- EPIDEMIOLOGY
9- TREATMENT
and finally video about the mechanism of action
if you van not open it
hit this link
https://www.youtube.com/watch?v=ZuUfGeoN_cw
i hope it meet what you want
world hepatitis day awareness presentation july 2022.pptxanjalatchi
World Hepatitis Day (WHD) is recognized annually on July 28th, the birthday of Dr. Baruch Blumberg (1925–2011). Dr. Blumberg discovered the hepatitis B virus in 1967, and 2 years later he developed the first hepatitis B vaccine
Should We Need Regular Screening For Hepatitis B.pdfsonaligautam19
In recent years, the importance of regular health screenings has become increasingly recognized, and one area that has garnered significant attention is the screening for Hepatitis B. Hepatitis B is a viral infection that primarily affects the liver, and if left untreated, it can lead to severe complications. With the guidance of Dr. Sonali Gautam, a prominent consultant gastroenterologist, we will delve into the reasons why regular screening for Hepatitis B is crucial and how it plays a pivotal role in preventing the spread of this disease.
This presentation on Viral Hepatitis is from a health awareness masterclass by Dr. Leju Benjamin Modi on 12th August 2023 via Zoom and YouTube Live stream as organised by Excellence Foundation for South Sudan.
The science of wellbeing, focusing on Viral Hepatitis a critical infectious disease. This masterclass aims to deepen your understanding of this disease, its impact on global health, and explore strategies for prevention and management. Whether you are a healthcare professional, researcher, or simply curious about public health, this masterclass is designed to provide valuable insights and knowledge.
Objectives: During this masterclass, participants will:
Understand the epidemiology, pathogenesis, and clinical presentation of Typhoid Fever, Malaria, and Viral Hepatitis.
Explore the risk factors associated with these diseases and their impact on vulnerable populations.
Discuss effective prevention strategies, including vaccination programs, vector control, and community education.
Examine the latest advancements in diagnosis, treatment, and management techniques.
Analyze the global burden of these diseases and their implications on public health policies and interventions.
This presentation was part of Embody's Safe Healthy Strong 2015 conference on sexuality education (www.ppwi.org/safehealthystrong). Embody is Planned Parenthood of Wisconsin's education and training programs. Learn more: www.ppwi.org/embody
DESCRIPTION
This workshop will outline the basics of Hepatitis C virus including a brief history, symptoms, and treatment.
The majority of the presentation will focus on the ways that HCV can be sexually transmitted. We will also talk about the increased risk of HCV for men who have sex with men (MSM) who are HIV positive, the lack of research around women who have sex with women’s (WSW) risk for HCV transmission, and the general controversy of calling HCV an STI.
ABOUT THE PRESENTERS
Rachael Cooper currently works as a Prevention Specialist at the AIDS Resource Center of Wisconsin and has worked in HIV/AIDS prevention and education both in Wisconsin and abroad. One of her current projects focuses heavily on educating at-risk populations about Hepatitis C transmission, symptoms, and care.
Veronica Shaheen is an Opiate Overdose Prevention Specialist, providing harm reduction services to
injection drug users at the AIDS Resource Center of Wisconsin (ARCW) LifePoint program by helping active users remove their personal risk for HIV, HCV, and other STIs. She also dedicates her time to overdose
prevention education and Naloxone training to any members of the community willing to help stop overdose deaths.
what you need to know about the liver ?
What is Hepatitis ?
Types of hepatitis
Hepatitis C virus
History & Statics
Causes
Prevention
Concequences
Symptoms
Analysis
Behaving with infected people
vaccine
Genotypes
Treatments
Management
Summary
all information about
it include :-
1- DEFINITION
2- SIGNS AND SYMPTOMS
3- MECHANISM
4- RISK FACTOR
5- COMPLICATIONS
6- PRECAUTION
7- PREVENTION
8- EPIDEMIOLOGY
9- TREATMENT
and finally video about the mechanism of action
if you van not open it
hit this link
https://www.youtube.com/watch?v=ZuUfGeoN_cw
i hope it meet what you want
world hepatitis day awareness presentation july 2022.pptxanjalatchi
World Hepatitis Day (WHD) is recognized annually on July 28th, the birthday of Dr. Baruch Blumberg (1925–2011). Dr. Blumberg discovered the hepatitis B virus in 1967, and 2 years later he developed the first hepatitis B vaccine
Should We Need Regular Screening For Hepatitis B.pdfsonaligautam19
In recent years, the importance of regular health screenings has become increasingly recognized, and one area that has garnered significant attention is the screening for Hepatitis B. Hepatitis B is a viral infection that primarily affects the liver, and if left untreated, it can lead to severe complications. With the guidance of Dr. Sonali Gautam, a prominent consultant gastroenterologist, we will delve into the reasons why regular screening for Hepatitis B is crucial and how it plays a pivotal role in preventing the spread of this disease.
This presentation on Viral Hepatitis is from a health awareness masterclass by Dr. Leju Benjamin Modi on 12th August 2023 via Zoom and YouTube Live stream as organised by Excellence Foundation for South Sudan.
The science of wellbeing, focusing on Viral Hepatitis a critical infectious disease. This masterclass aims to deepen your understanding of this disease, its impact on global health, and explore strategies for prevention and management. Whether you are a healthcare professional, researcher, or simply curious about public health, this masterclass is designed to provide valuable insights and knowledge.
Objectives: During this masterclass, participants will:
Understand the epidemiology, pathogenesis, and clinical presentation of Typhoid Fever, Malaria, and Viral Hepatitis.
Explore the risk factors associated with these diseases and their impact on vulnerable populations.
Discuss effective prevention strategies, including vaccination programs, vector control, and community education.
Examine the latest advancements in diagnosis, treatment, and management techniques.
Analyze the global burden of these diseases and their implications on public health policies and interventions.
This presentation was part of Embody's Safe Healthy Strong 2015 conference on sexuality education (www.ppwi.org/safehealthystrong). Embody is Planned Parenthood of Wisconsin's education and training programs. Learn more: www.ppwi.org/embody
DESCRIPTION
This workshop will outline the basics of Hepatitis C virus including a brief history, symptoms, and treatment.
The majority of the presentation will focus on the ways that HCV can be sexually transmitted. We will also talk about the increased risk of HCV for men who have sex with men (MSM) who are HIV positive, the lack of research around women who have sex with women’s (WSW) risk for HCV transmission, and the general controversy of calling HCV an STI.
ABOUT THE PRESENTERS
Rachael Cooper currently works as a Prevention Specialist at the AIDS Resource Center of Wisconsin and has worked in HIV/AIDS prevention and education both in Wisconsin and abroad. One of her current projects focuses heavily on educating at-risk populations about Hepatitis C transmission, symptoms, and care.
Veronica Shaheen is an Opiate Overdose Prevention Specialist, providing harm reduction services to
injection drug users at the AIDS Resource Center of Wisconsin (ARCW) LifePoint program by helping active users remove their personal risk for HIV, HCV, and other STIs. She also dedicates her time to overdose
prevention education and Naloxone training to any members of the community willing to help stop overdose deaths.
what you need to know about the liver ?
What is Hepatitis ?
Types of hepatitis
Hepatitis C virus
History & Statics
Causes
Prevention
Concequences
Symptoms
Analysis
Behaving with infected people
vaccine
Genotypes
Treatments
Management
Summary
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
1. o Name: khadiijo Yuusuf cali
o Faculty: health science
o Department: laboratory
o Corse lecture: Reseach methodology
o Teacher name: dahir okay
o Assignment hepatitis B virus
2. 2
Key terms
1. Definition of hepatitis B virus
2. Causes of hepatitis B virus
3. Transmission of hepatitis B virus
4. Signs and symptoms
5. How to prevent hepatitis B virus
6. Acute and chronic hepatitis B virus
7. Risk factor and Compilation
Hepatitis B virus
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). For most
people, hepatitis B is short term, also called acute, and lasts less than six months. But
for others, the infection becomes chronic, meaning it lasts more than six months.
Having chronic hepatitis B increases your risk of developing liver failure, liver cancer or
cirrhosis — a condition that permanently scars the liver.
Most adults with hepatitis B recover fully, even if their symptoms are severe. Infants
and children are more likely to develop a long-lasting hepatitis B infection. This is
known as a chronic infection.
A vaccine can prevent hepatitis B, but there's no cure if you have the condition. If
you're infected, taking certain precautions can help prevent spreading the virus to
others.
Symptoms
Symptoms of acute hepatitis B range from mild to severe. They usually appear about 1
to 4 months after you've been infected, although you could see them as early as two
weeks after you're infected. Some people, usually young children, may not have any
symptoms.
3. 3
Hepatitis B signs and symptoms may include:
Abdominal pain
Dark urine
Fever
Joint pain
Loss of appetite
Nausea and vomiting
Weakness and fatigue
Yellowing of the skin and the whites of the eyes, also called jaundice
Problems
Causes
Hepatitis B infection is caused by the hepatitis B virus (HBV). The virus is passed from
person to person through blood, semen or other body fluids. It does not spread by
sneezing or coughing.
Common ways that HBV can spread are:
Sexual contact. You may get hepatitis B if you have unprotected sex with
someone who is infected. The virus can pass to you if the person's blood,
saliva, semen or vaginal secretions enter your body.
Sharing of needles. HBV easily spreads through needles and syringes
contaminated with infected blood. Sharing IV drug paraphernalia puts you
at high risk of hepatitis B.
Accidental needle sticks. Hepatitis B is a concern for health care workers
and anyone else who comes in contact with human blood.
Mother to child. Pregnant women infected with HBV can pass88 the virus
to their babies during childbirth. However, the newborn can be vaccinated
to avoid getting infected in almost all cases. Talk to your provider about
being tested for hepatitis B if you are pregnant or want to become pregnant
Acute vs. chronic hepatitis B
Hepatitis B infection may be short-lived, also called acute. Or it might last a long time,
also known as chronic.
4. 4
Acute hepatitis B infection lasts less than six months. Your immune
system likely can clear acute hepatitis B from your body, and you should
recover completely within a few months. Most people who get hepatitis B
as adults have an acute infection, but it can lead to chronic infection.
Chronic hepatitis B infection lasts six months or longer. It lingers
because your immune system can't fight off the infection. Chronic hepatitis
B infection may last a lifetime, possibly leading to serious illnesses such as
cirrhosis and liver cancer. Some people with chronic hepatitis B may have
no symptoms at all. Some may have ongoing fatigue and mild symptoms
of acute hepatitis.
The younger you are when you get hepatitis B — particularly newborns or children
younger than 5 — the higher your risk of the infection becoming chronic. Chronic
infection may go undetected for decades until a person becomes seriously ill from liver
disease.
Risk factors
Hepatitis B spreads through contact with blood, semen or other body fluids from an
infected person. Your risk of hepatitis B infection increases if you:
Have unprotected sex with multiple sex partners or with someone who's
infected with HBV
Share needles during IV drug use
Are a man who has sex with other men
Live with someone who has a chronic HBV infection
Are an infant born to an infected mother
Have a job that exposes you to human blood
Travel to regions with high infection rates of HBV, such as Asia, the Pacific
Islands, Africa and Eastern Europe
Complications
Having a chronic HBV infection can lead to serious complications, such as:
5. 5
Scarring of the liver (cirrhosis). The inflammation associated with a
hepatitis B infection can lead to extensive liver scarring (cirrhosis), which
may impair the liver's ability to function.
Liver cancer. People with chronic hepatitis B infection have an increased
risk of liver cancer.
Liver failure. Acute liver failure is a condition in which the vital functions of
the liver shut down. When that occurs, a liver transplant is necessary to
stay alive.
Reactivation of the hepatitis B virus. People with chronic hepatitis B
who have suppression of their immune system are prone to reactivation of
the hepatitis B virus. This can lead to significant liver damage or even liver
failure. This includes people on immunosuppressive medications, such as
high-dose corticosteroids or chemotherapy. Before taking these
medications, you should be tested for hepatitis B. If you test positive for
hepatitis B, you should be seen by a liver specialist (hepatologist) before
starting these therapies.
Other conditions. People with chronic hepatitis B may develop kidney
disease or inflammation of blood vessels.
The best way to prevent hepatitis B is to get vaccinated. All adults aged 18-59
should receive the vaccine and any adult who requests it may get the
vaccine. All adults 18 years and older should get screened at least once in
their lifetime.
Prevention
The hepatitis B vaccine is typically given as two injections separated by a month or
three or four injections over six months, depending on which vaccine is given. You
can't get hepatitis B from the vaccine. The hepatitis B vaccine is recommended by the
United States Advisory Committee on Immunization Practices for adults 19 to 59 years
of age who do not have a contraindication to the vaccine.
The hepatitis B vaccine is also strongly recommended for:
Newborns
Children and adolescents not vaccinated at birth
Those who work or live in a center for people who are developmentally
disabled
6. 6
People who live with someone who has hepatitis B
Health care workers, emergency workers and other people who come into
contact with blood
Anyone who has a sexually transmitted infection, including HIV
Men who have sex with men
People who have multiple sexual partners
Sexual partners of someone who has hepatitis B
People who inject illegal drugs or share needles and syringes
People with chronic liver disease
People with end-stage kidney disease
Travelers planning to go to an area of the world with a high hepatitis B
infection rate
Screening and Testing
2023 Screening and Testing Recommendations
Testing and Vaccination
Serology
Vaccination of Infants and Children
Guidelines and Recommendations
Schedules and Dosages
Standing Orders
Vaccination of Adults
Guidelines and Recommendations
Adults recommended to receive HepB vaccine
Implementation Guideline
NAIIS Call to Action
7. 7
Background study
Viral hepatitis b in the world or Global
Hepatitis B Affects Millions of People Around the World
Hepatitis B affects approximately 296 million people, including over 6
million children under the age of 5.
Hepatitis B contributes to an estimated 820,000 deaths every year.
25% of chronic hepatitis B infections progress to liver cancer.
Hepatitis B Causes Serious, Lifelong Health Problems
Hepatitis B is the leading cause of liver cancer globally. It can also cause:
Liver damage
Cirrhosis
Liver failure
Death
Hepatitis B virus in th African
More than 91 million Africans live with Hepatitis B or C, which are the deadliest
strains of the virus, according to a World Health Organization (WHO)
scorecard that launched today – ahead of tomorrow’s World Hepatitis Day.
The Viral Hepatitis Scorecard 2021 looks at data from the African
region but focuses on Hepatitis B and C, both of which cause liver cirrhosis and
cancer. It found that in 19 countries, more than 8% of the population is infected
with Hepatitis B, while in 18 countries, more than 1% of the population
lives with Hepatitis C. In 2020, the African region accounted for 26% of the global
burden for Hepatitis B and C and 125,000 associated deaths.
8. 8
Around 70% of Hepatitis B infections worldwide occur in Africa. It can take decades
after infection from the virus before an individual starts manifesting symptoms.
Thus, what is particularly worrying for the future is that the region accounts for 70%
of the global Hepatitis B cases found among children younger than 5 years, with 4.5
million African children infected. Currently, 33 countries have a Hepatitis B
prevalence of more than 1% among children younger than 5 years, which is a small
improvement from 40 countries in 2019.
Hepatitis B virus in somalia
Hepatitis A is a liver disease caused by HAV, and it occurs
worldwide. This virus thus creates a public health concern,
primarily in developing countries, due to its persistent
circulation in the environment. Among the studies presented in
Somalia, more than 90% of children had the HAV antibody by
the age of 4 years[15-19]. In 1992, Mohamud KB and his
colleagues studied a Somali sample of 593 subjects who were
healthy rural and urban volunteers and child outpatients ages 0-
83 years in three villages in Somalia (Mogadishu area: Buur-
Ful village; Jowhar District: Mooda Moode; and Bur-Hakaba
District and Bajuni Islands: Kismaio District). This sample
showed a very high rate of HAV exposure of approximately
90%[15]. Another study by Bile et al[16] conducted at two
institutions for children in Somalia (Shebeli: 596 subjects and
Societe Organization Social, SOS: 76 subjects) showed a very
high rate of HAV in the two samples of 96% and 59%,
respectively. One study indicated that HAV in Somalia occurs
primarily between 4 mo to 4 years of age, because the child has
passive immunity from maternal antibodies during the first 3
mo of life[17]. Sebastiani et al [18] presented a result of 90.6%.
Recommendation
9. 9
Hepatitis B Vaccine Recommendations
International: The World Health Organization (WHO) recommends the hepatitis B vaccine for
all newborns, children up to 18 years of age, and all adults at higher risk for infection (see
below for risk factors).
United States: The U.S. Centers for Disease Control and Prevention (CDC) recommends the
hepatitis B vaccine for all newborns, children up to age 18, adults 19-59 years of age, and
adults 60 and older who are at high-risk for infection (see below for risk factors)
Persons most at risk for infection:
Every person may be at some risk for a hepatitis B infection during their lifetime, so all people
should consider getting the hepatitis B vaccine. However, some groups are more likely to be
exposed to the hepatitis B virus. See below for the CDC’s list of people at increased risk of
infection:
Infants born to mothers who are living with hepatitis B
All infants, beginning at birth
Unvaccinated children aged <19
Susceptible sexual partners of people with hepatitis B infection
Sexually active persons who are not in a long-term, mutually monogamous
relationship (e.g., more than one sex partner during the previous six months)
Persons seeking evaluation or treatment for a sexually transmitted infection
Men who have sex with men
People with current or recent drug use
Susceptible household contacts of people with hepatitis B infection
Healthcare and public safety workers at risk for exposure to blood
Persons with end-stage renal disease, including pre-dialysis, hemodialysis, peritoneal
dialysis, and home dialysis patients
Residents and staff of facilities for persons with developmental disabilities
Travelers to and families adopting from countries where hepatitis B is common (e.g.
Asia, Africa, South America, Pacific Islands, Eastern Europe, and the Middle East)
Persons with chronic liver disease, other than hepatitis B (e.g. cirrhosis, fatty liver
disease, etc.)
Persons with hepatitis C infection
Persons with HIV infection
10. 10
People with diabetes, as decided by their provider
All persons seeking protection from HBV infection — acknowledgment of a specific
risk factor is not a requirement for vaccination
Conclusion
Our study demonstrates a high prevalence of all forms of viral hepatitis in
Somalia and it also indicates that chronic HBV was the commonest cause of
chronic liver disease. This highlights needs for urgent public health interventions
and strategic policy directions to controlling the burden of the disease.
Keywords: Viral hepatitis, Hepatitis A virus, Hepatitis B virus, Hepatitis C virus,
Hepatitis D virus, Hepatitis E virus, Systematic review, Meta-analysis, Somalia
Core tip: This is the first article reviewing epidemiology of viral hepatitis in
Somalia with systematic review and meta-analysis of the published and
unpublished reports from 1977 to 2016 among prevalence of all types’ viral
hepatitis in Somalia.